HIGH NORMAL ALT AND BORDERLINE HBV DNA WERE PREDICTORS FOR FUTURE TREATMENT ELIGIBILITY IN CHRONIC HEPATITIS B (CHB) PATIENTS WHO INITIALLY DID NOT MEET CRITERIA

被引：0

作者：

Uribe, L. ^{[1
]}

Nguyen, N. ^{[2
]}

Nguyen, L. ^{[1
]}

Kim, L. H. ^{[3
]}

Trinh, H. N. ^{[4
]}

Nguyen, M. H. ^{[5
]}

机构：

[1] Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA

[2] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA

[3] Stanford Univ, Sch Med, Dept Gastroenterol & Hepatol, Palo Alto, CA 94304 USA

[4] San Jose Gastroenterol, San Jose, CA USA

[5] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA

来源：

JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期

关键词：

D O I：

10.1016/S0168-8278(14)60854-0

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P692

引用

页码：S299 / S300

页数：2

共 43 条

[1] High Normal ALT and Borderline HBV DNA Were Predictors for Future Treatment Eligibility in Chronic Hepatitis B (CHB) Patients Who Initially Did Not Meet Criteria
Uribe, Lindsay
Nghia Nguyen
Nguyen, Long H.
Kim, Lily H.
Trinh, Huy N.
Wong, Christopher C.
Wong, Clifford
Nguyen, Mindie H.
GASTROENTEROLOGY, 2014, 146 (05) : S964 - S964
[2] Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation
Lindsay A. Uribe
Nghia Nguyen
Lily Kim
Huy N. Trinh
Christopher Wong
Clifford Wong
Long H. Nguyen
Mindie H. Nguyen
Digestive Diseases and Sciences, 2016, 61 : 618 - 625
[3] Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation
Uribe, Lindsay A.
Nguyen, Nghia
Kim, Lily
Trinh, Huy N.
Wong, Christopher
Wong, Clifford
Nguyen, Long H.
Nguyen, Mindie H.
DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (02) : 618 - 625
[4] High prevalence of significant histologic disease in patients with chronic hepatitis B (CHB) and normal ALT
Nguyen, Mindie H.
Trinh, Huy N.
Garcia, Ruel T.
Phan, Jeanine
Nguyen, Gloria H.
Weiss, Gerald
Nguyen, Huy
Nguyen, Khanh
Keeffe, Emmet B.
HEPATOLOGY, 2007, 46 (04) : 680A - 680A
[5] Outcomes of Patients With Chronic Hepatitis B Who Do Not Meet Criteria for Antiviral Treatment at Presentation
Yapali, Suna
Talaat, Nizar
Fontana, Robert J.
Oberhelman, Kelly
Lok, Anna S.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (01) : 193 - U275
[6] Outcome of Chronic Hepatitis B Patients Who Do Not Meet Criteria for Antiviral Treatment At Presentation
Yapali, Suna
Talaat, Nizar
Fontana, Robert J.
Conjeevaram, Hari
Oberhelman, Kelly
Lok, Anna S.
GASTROENTEROLOGY, 2014, 146 (05) : S962 - S962
[7] Total serum bile acids predict therapy for HBeAg-negative chronic hepatitis B patients with borderline ALT and high HBV DNA
Xie, Ran
Li, Jiao
Zhang, Hao
Wang, Ling-Mei
Huang, Cheng-Rong
Chen, Li-Wen
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2022, 16 (08): : 1336 - 1342
[8] Predictive value of serum ALT and HBV DNA levels on response to interferon (IFN) therapy in patients (PTS) with chronic hepatitis B (CHB).
Lok, ASF
Ghany, MG
Ayola, B
GASTROENTEROLOGY, 1996, 110 (04) : A1253 - A1253
[9] High Frequency of Flares in Alanine Aminotransferase (ALT) And Hepatitis B Virus (HBV) DNA During Pregnancy And Postpartum in Women With Chronic Hepatitis B (CHB) Who Discontinued Therapy Prior to or During Early Pregnancy
Chang, Christine Y.
Aziz, Natali
Poongkunran, Mugilan
Javaid, Asad
Trinh, Huy N.
Lau, Daryl
Nguyen, Mindie H.
HEPATOLOGY, 2016, 64 : 920A - 920A
[10] Prevalence of HBV DNA polymerase (B-DNA pol) mutations in 345 patients with treatment-naive chronic hepatitis B (CHB)
Nguyen, Minche H.
Trinh, Huy N.
Garcia, Ruel T.
Nguyen, Long H.
Vutien, Philip
Ha, Nghiem B.
Nguyen, Huy A.
Nguyen, Khanh K.
Keeffe, Emmet B.
Ha, Nghi B.
GASTROENTEROLOGY, 2008, 134 (04) : A310 - A310

← 1 2 3 4 5 →